Vanda Pharmaceuticals Inc. revenue increases to $62.50 million in quarter ended Mar 31, 2023 from previous quarter
By USInMinutes - May 03, 2023, 05:04 PM ET
Last Updated - Jul 18, 2023, 03:41 PM EDT
Key fundamental financials
profit of $3.25 million
Revenue of $62.50 million
earnings per share of $0.06
Current Reporting
Revenue
Net Income
Profit/Loss
Mar 2023
$62.50 million
$3.25 million
profit
Sep 2022
$65,318
$3,270
profit
Jun 2022
$64.39 million
$2.57 million
profit
Vanda Pharmaceuticals Inc. [VNDA] has reported $3.25 million profit for the fiscal quarter ending Mar 31, 2023 while the earnings for the same period were $0.06 per share.
Revenue for the quarter was $62.50 million with operating income of $2 million.
The Rockville, District of Columbia (DC)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $535.74 million.
